ArticleOncogenesis2021

Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma.

Darko Bosnakovski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.